| 000 | 01643 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515195626.0 | ||
| 264 | 0 | _c20101015 | |
| 008 | 201010s 0 0 eng d | ||
| 022 | _a1365-2141 | ||
| 024 | 7 |
_a10.1111/j.1365-2141.2009.08023.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSinha, Shirshendu | |
| 245 | 0 | 0 |
_aImpact of dexamethasone responsiveness on long term outcome in patients with newly diagnosed multiple myeloma. _h[electronic resource] |
| 260 |
_bBritish journal of haematology _cMar 2010 |
||
| 300 |
_a853-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xadministration & dosage |
| 650 | 0 | 4 |
_aDexamethasone _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Myeloma _xdrug therapy |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aRajkumar, S Vincent | |
| 700 | 1 | _aLacy, Martha Q | |
| 700 | 1 | _aHayman, Suzanne R | |
| 700 | 1 | _aBuadi, Francis K | |
| 700 | 1 | _aDispenzieri, Angela | |
| 700 | 1 | _aDingli, David | |
| 700 | 1 | _aKyle, Robert A | |
| 700 | 1 | _aGertz, Morie A | |
| 700 | 1 | _aKumar, Shaji | |
| 773 | 0 |
_tBritish journal of haematology _gvol. 148 _gno. 6 _gp. 853-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2141.2009.08023.x _zAvailable from publisher's website |
| 999 |
_c19341384 _d19341384 |
||